| Study name |
The effect of MElatonin on Depressive symptoms, Anxiety, CIrcadian and Sleep disturbances in patients after acute coronary syndrome (MEDACIS): study protocol for a randomised controlled trial |
| Methods |
multicenter, double‐blinded, placebo‐controlled, randomised clinical trial |
| Participants |
target size: 240 |
| Interventions |
25 mg exogenous melatonin |
| Outcomes |
primary: Incidence of clinically significant depressive symptoms measured by the Major Depression Inventory (MDI) |
| Starting date |
2015 |
| Contact information |
michael_madsen88@hotmail.com |
| Notes |
The study is led by Dr. Michael Tvilling Madsen (principal investigator) in Denmark (NCT02451293). Dr. Madsen was contacted again in March 2020 but we were unable to receive any additional information about the status of the study. |
